These findings support the concept that pulmonary inflammation helps to create a pro-metastatic environment in the lungs, and suggest that small molecule activators of SHIP may be a therapeutically useful strategy to restrict the accumulation and activation of tumor-induced myeloid cells in tissues and aid in the prevention or treatment of metastases in breast cancer patients. The gene discussed is INPP5D; the disease is neoplasm.